These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9549807)

  • 1. The multi-centre assessment of quality of life: the Interdisciplinary Group for Cancer Care Evaluation (GIVIO) experience in Italy.
    Mosconi P; Torri V; Cifani S; Ruggiata R; Meyerowitz BE; Apolone G; Liberati A
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):577-85. PubMed ID: 9549807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions.
    Hahn EA; Webster KA; Cella D; Fairclough DL
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):547-59. PubMed ID: 9549804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with QOL assessment in multi-centre German breast cancer trials.
    Olschewski M
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):571-5. PubMed ID: 9549806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensuring the quality of quality of life data: the Southwest Oncology Group experience.
    Moinpour CM; Lovato LC
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):641-51. PubMed ID: 9549813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research.
    Bernhard J; Gusset H; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):633-9. PubMed ID: 9549812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data.
    Coates A; Gebski V
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):533-40. PubMed ID: 9549802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial.
    Ganz PA; Day R; Costantino J
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):613-22. PubMed ID: 9549810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Zee B
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):603-12. PubMed ID: 9549809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer.
    Kiebert GM; Curran D; Aaronson NK
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):561-9. PubMed ID: 9549805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance in quality of life data: a Norwegian experience.
    Kaasa S; Hjermstad MJ; Jordhøy MS; Wisløff F; Loge JH
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):623-32. PubMed ID: 9549811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.
    Bernhard J; Peterson HF; Coates AS; Gusset H; Isley M; Hinkle R; Gelber RD; Castiglione-Gertsch M; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):587-601. PubMed ID: 9549808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why are missing quality of life data a problem in clinical trials of cancer therapy?
    Fairclough DL; Peterson HF; Chang V
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):667-77. PubMed ID: 9549815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups.
    Fallowfield L
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):541-6. PubMed ID: 9549803
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying the types of missingness in quality of life data from clinical trials.
    Curran D; Bacchi M; Schmitz SF; Molenberghs G; Sylvester RJ
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):739-56. PubMed ID: 9549820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life end points in cancer clinical trials: review and recommendations.
    Moinpour CM; Feigl P; Metch B; Hayden KA; Meyskens FL; Crowley J
    J Natl Cancer Inst; 1989 Apr; 81(7):485-95. PubMed ID: 2646455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missing quality of life data in cancer clinical trials: serious problems and challenges.
    Bernhard J; Cella DF; Coates AS; Fallowfield L; Ganz PA; Moinpour CM; Mosconi P; Osoba D; Simes J; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):517-32. PubMed ID: 9549801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and compliance of automated measurement of quality of life in oncology practice.
    Wright EP; Selby PJ; Crawford M; Gillibrand A; Johnston C; Perren TJ; Rush R; Smith A; Velikova G; Watson K; Gould A; Cull A
    J Clin Oncol; 2003 Jan; 21(2):374-82. PubMed ID: 12525532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete quality of life data in randomized trials: missing items.
    Fayers PM; Curran D; Machin D
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):679-96. PubMed ID: 9549816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life as a primary end point in oncology.
    Roila F; Cortesi E
    Ann Oncol; 2001; 12 Suppl 3():S3-6. PubMed ID: 11804381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.